ZCMD logo

ZHONGCHAO INC-CLASS A

ZCMDNASDAQ
πŸ† #5533 by market capUS Equity
$315.89β–Ό $22.74 (βˆ’7.20%)
Simulated price
πŸ””
Track ZCMD
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 7.2%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$30,058
Small Cap
πŸ“ˆRevenue Growth (YoY)
-28.3%
Declining
πŸ“ŠGross Margin
43.8%
Healthy
πŸ’΅FCF Margin
6.1%
Moderate
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
40
Weak
No chart data available for ZCMD.

Trading Snapshot

Day Range
$313.56 – $317.85
52-Week Range
$0.71 – $967.20
Volume
$1.82B
Avg Volume
$1.45B
Shares Outstanding
34,729
Next Earnings
Dec 14, 2026

Fundamentals Snapshot

Annual Revenue
$11M
Last Q Revenue
$6M
P/E Ratio
-0.0
P/S Ratio
0.0x
EPS (TTM)
$-169.29
Dividend Yield
0.00%
Dilution (1yr)
+496.5%

Why Investors Own ZCMD

  • βœ“High-growth profile β€” revenue up -1.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 71% gross margin and 29% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ZCMD logo

ZHONGCHAO INC-CLASS A

ZCMD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$11Mβ–Ό βˆ’28.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
42.5%β–Ό βˆ’24.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$6Mβ–² +1714.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$693Kβ–Ό βˆ’115.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
37Kβ–² +496.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$8Mβ–² +$288K YoY
StockOtter Β· stockotter.space

About ZHONGCHAO INC-CLASS A

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
40/100

Analyst Price Target

β“˜
Average Target
$316.76
β–² +0.3% Upside
High Target$375.69
Low Target$288.97
Based on 41 analysts

Latest News & Updates